Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
192.00
0.00 (0.00%)
Sep 2, 2026, 9:37 AM HKT

HKG:2637 Statistics

Total Valuation

HKG:2637 has a market cap or net worth of HKD 15.11 billion. The enterprise value is 13.83 billion.

Market Cap15.11B
Enterprise Value 13.83B

Important Dates

The last earnings date was Friday, August 28, 2026.

Earnings Date Aug 28, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2637 has 78.71 million shares outstanding. The number of shares has increased by 11.84% in one year.

Current Share Class 78.71M
Shares Outstanding 78.71M
Shares Change (YoY) +11.84%
Shares Change (QoQ) n/a
Owned by Insiders (%) 28.81%
Owned by Institutions (%) 6.04%
Float 14.26M

Valuation Ratios

The trailing PE ratio is 83.18 and the forward PE ratio is 65.05.

PE Ratio 83.18
Forward PE 65.05
PS Ratio 22.04
PB Ratio 7.84
P/TBV Ratio 7.97
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 79.72
EV / Sales 20.17
EV / EBITDA 64.22
EV / EBIT 67.50
EV / FCF n/a

Financial Position

The company has a current ratio of 6.85, with a Debt / Equity ratio of 0.05.

Current Ratio 6.85
Quick Ratio 5.51
Debt / Equity 0.05
Debt / EBITDA 0.43
Debt / FCF n/a
Interest Coverage 29.53

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 29.93%
Return on Capital Employed (ROCE) 10.20%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count200
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, HKG:2637 has paid 10.64 million in taxes.

Income Tax 10.64M
Effective Tax Rate 5.78%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 191.35
200-Day Moving Average 171.33
Relative Strength Index (RSI) 47.29
Average Volume (20 Days) 153,345

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2637 had revenue of HKD 685.64 million and earned 173.48 million in profits. Earnings per share was 2.31.

Revenue685.64M
Gross Profit 555.59M
Operating Income 204.89M
Pretax Income 184.12M
Net Income 173.48M
EBITDA 212.96M
EBIT 204.89M
Earnings Per Share (EPS) 2.31
Full Income Statement

Balance Sheet

The company has 1.38 billion in cash and 93.28 million in debt, with a net cash position of 1.28 billion or 16.29 per share.

Cash & Cash Equivalents 1.38B
Total Debt 93.28M
Net Cash 1.28B
Net Cash Per Share 16.29
Equity (Book Value) 1.93B
Book Value Per Share 24.49
Working Capital 1.53B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 8.16M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 81.03%, with operating and profit margins of 29.88% and 25.30%.

Gross Margin 81.03%
Operating Margin 29.88%
Pretax Margin 26.85%
Profit Margin 25.30%
EBITDA Margin 31.06%
EBIT Margin 29.88%
FCF Margin n/a

Dividends & Yields

HKG:2637 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.84%
Shareholder Yield -11.84%
Earnings Yield 1.15%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Analyst Forecast

The average price target for HKG:2637 is 292.89, which is 52.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target 292.89
Price Target Difference 52.55%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (3Y) 18.21%
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2